TP53 and myelodysplastic syndrome: Moreover, according to a recent study by Bernald et al. that illustrates the treatment outcome is similar between monoallelic TP53 mutation and TP53 wild-type MDS patients, which monoallelic and biallelic TP53 mutation are found in one-third and two-third of MDS patients, respectively [13].